TY - JOUR AU - Baccarani, M. AU - Deininger, M. W. AU - Rosti, G. AU - Hochhaus, A. AU - Soverini, S. AU - Apperley, J. F. PY - 2013 DA - 2013// TI - European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-05-501569 DO - 10.1182/blood-2013-05-501569 ID - Baccarani2013 ER - TY - JOUR AU - Sherbenou, D. W. AU - Hantschel, O. AU - Kaupe, I. AU - Willis, S. AU - Bumm, T. AU - Turaga, L. P. PY - 2010 DA - 2010// TI - BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2008-10-183665 DO - 10.1182/blood-2008-10-183665 ID - Sherbenou2010 ER - TY - JOUR AU - Gibbons, D. L. AU - Pricl, S. AU - Posocco, P. AU - Laurini, E. AU - Fermeglia, M. AU - Sun, H. PY - 2014 DA - 2014// TI - Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1321173111 DO - 10.1073/pnas.1321173111 ID - Gibbons2014 ER - TY - JOUR AU - Khorashad, J. S. AU - Kelley, T. W. AU - Szankasi, P. AU - Mason, C. C. AU - Soverini, S. AU - Adrian, L. T. PY - 2013 DA - 2013// TI - BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-05-431379 DO - 10.1182/blood-2012-05-431379 ID - Khorashad2013 ER - TY - JOUR AU - Zabriskie, M. S. AU - Eide, C. A. AU - Tantravahi, S. K. AU - Vellore, N. A. AU - Estrada, J. AU - Nicolini, F. E. PY - 2014 DA - 2014// TI - BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia JO - Cancer Cell VL - 26 UR - https://doi.org/10.1016/j.ccr.2014.07.006 DO - 10.1016/j.ccr.2014.07.006 ID - Zabriskie2014 ER - TY - JOUR AU - Gruber, F. X. AU - Lundan, T. AU - Goll, R. AU - Silye, A. AU - Mikkola, I. AU - Rekvig, O. P. PY - 2012 DA - 2012// TI - BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations? JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-010-9781-z DO - 10.1007/s12032-010-9781-z ID - Gruber2012 ER - TY - JOUR AU - Sherbenou, D. W. AU - Hantschel, O. AU - Turaga, L. AU - Kaupe, I. AU - Willis, S. AU - Bumm, T. PY - 2008 DA - 2008// TI - Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia JO - Leukemia VL - 22 UR - https://doi.org/10.1038/leu.2008.65 DO - 10.1038/leu.2008.65 ID - Sherbenou2008 ER - TY - JOUR AU - Kastner, R. AU - Zopf, A. AU - Preuner, S. AU - Proll, J. AU - Niklas, N. AU - Foskett, P. PY - 2014 DA - 2014// TI - Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing JO - Eur J Cancer VL - 50 UR - https://doi.org/10.1016/j.ejca.2013.11.030 DO - 10.1016/j.ejca.2013.11.030 ID - Kastner2014 ER - TY - JOUR AU - Soverini, S. AU - Benedittis, C. AU - Machova Polakova, K. AU - Brouckova, A. AU - Horner, D. AU - Iacono, M. PY - 2013 DA - 2013// TI - Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-03-487728 DO - 10.1182/blood-2013-03-487728 ID - Soverini2013 ER - TY - JOUR AU - Eid, J. AU - Fehr, A. AU - Gray, J. AU - Luong, K. AU - Lyle, J. AU - Otto, G. PY - 2009 DA - 2009// TI - Real-time DNA sequencing from single polymerase molecules JO - Science VL - 323 UR - https://doi.org/10.1126/science.1162986 DO - 10.1126/science.1162986 ID - Eid2009 ER - TY - JOUR AU - Roberts, R. J. AU - Carneiro, M. O. AU - Schatz, M. C. PY - 2013 DA - 2013// TI - The advantages of SMRT sequencing JO - Genome Biol VL - 14 UR - https://doi.org/10.1186/gb-2013-14-6-405 DO - 10.1186/gb-2013-14-6-405 ID - Roberts2013 ER - TY - JOUR AU - Laudadio, J. AU - Deininger, M. W. AU - Mauro, M. J. AU - Druker, B. J. AU - Press, R. D. PY - 2008 DA - 2008// TI - An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy JO - J Mol Diagn: JMD VL - 10 UR - https://doi.org/10.2353/jmoldx.2008.070128 DO - 10.2353/jmoldx.2008.070128 ID - Laudadio2008 ER - TY - JOUR AU - Parker, W. T. AU - Phillis, S. R. AU - Yeung, D. T. AU - Hughes, T. P. AU - Scott, H. S. AU - Branford, S. PY - 2014 DA - 2014// TI - Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-05-573485 DO - 10.1182/blood-2014-05-573485 ID - Parker2014 ER - TY - JOUR AU - Lee, T. S. AU - Ma, W. AU - Zhang, X. AU - Giles, F. AU - Cortes, J. AU - Kantarjian, H. PY - 2008 DA - 2008// TI - BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0482 DO - 10.1158/1535-7163.MCT-08-0482 ID - Lee2008 ER - TY - JOUR AU - Ma, W. AU - Giles, F. AU - Zhang, X. AU - Wang, X. AU - Zhang, Z. AU - Lee, T. S. PY - 2011 DA - 2011// TI - Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors JO - Int J Lab Hematol VL - 33 UR - https://doi.org/10.1111/j.1751-553X.2010.01291.x DO - 10.1111/j.1751-553X.2010.01291.x ID - Ma2011 ER - TY - JOUR AU - O’Hare, T. AU - Zabriskie, M. S. AU - Eide, C. A. AU - Agarwal, A. AU - Adrian, L. T. AU - You, H. PY - 2011 DA - 2011// TI - The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-05-349191 DO - 10.1182/blood-2011-05-349191 ID - O’Hare2011 ER - TY - JOUR AU - Gaillard, J. B. AU - Arnould, C. AU - Bravo, S. AU - Donadio, D. AU - Exbrayat, C. AU - Jourdan, E. PY - 2010 DA - 2010// TI - Exon 7 deletion in the bcr-abl gene is frequent in chronic myeloid leukemia patients and is not correlated with resistance against imatinib JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-10-0595 DO - 10.1158/1535-7163.MCT-10-0595 ID - Gaillard2010 ER -